Francesca Maltecca

Group leader @ Ospedale San Raffaele. Interested in cerebellar ataxias, Purkinje cells and mitochondria.

[Luca Rampoldi @lrampold]

🔬Just published in @asnpublications In a mouse model of #ADTKD-UMOD, moderate calorie restriction restores autophagy, reduces ER retention of mutant #uromodulin, and significantly delays kidney disease.

https://t.co/w0TLarLkmT

[Francesca Maltecca @FrancescaMalt12]

Very proud of @DanieleRitis, a super talented postdoc in my lab, who has been awarded with the Cariplo grant for young researchers on a project ai med at testing our gene therapy approach in #ARSACS preclinical models.

https://t.co/o8EMpr81QS

[Francesca Maltecca @FrancescaMalt12]

https://t.co/yAPJpmRQvB

[Francesca Maltecca @FrancescaMalt12]

Tomorrow, 10am CDT I will give a webinar on SCA28 and SPAX5 organized by NAF

[Francesca Maltecca @FrancescaMalt12]

Thanks to @NAF_Ataxia for funding our preclinical gene therapy approach for #SPAX5

[Francesca Maltecca @FrancescaMalt12]

Proud to get the cover page of the March issue on #Annals of Neurology for our work on Retina and brain imaging biomarkers in #ARSACS

[ARSACS Ataxie Charlevoix-Saguenay @FondationARSACS]

Recherche publiée dans 'Annals of Neurology' en 2024 / Research published in 'Annals of Neurology' in 2024.

”Longitudinal Imaging Biomarkers Correlate with Progressive Motor Deficit in the Mouse Model of Charlevoix-Saguenay Ataxia”.

https://t.co/wnuqaUD8Wd

[Francesca Maltecca @FrancescaMalt12]

Happy to share our last paper on Annals of Neurology, identifying non invasive longitudinal biomarkers of disease progression in the ARSACS mouse model
https://t.co/ZTEsxfcTZY

[Francesca Maltecca @FrancescaMalt12]

Honored to present our work about preclinical treatment of SPAX5 at @icar_ataxia @DanieleRitis @CamiFranchino

[Francesca Maltecca @FrancescaMalt12]

@Erica_Spirit0

[Francesca Maltecca @FrancescaMalt12]

Erica Spirito @erica_spirit presenting our new data on sacsin and Cav2.1 @icar_ataxia @cacna1a @Soniagobe. Very proud of you

[Francesca Maltecca @FrancescaMalt12]

@DanieleRitis presenting his new paper on ARSACS molecular diagnosis at @icar_ataxia

[International Congress for Ataxia Research (ICAR) @icar_ataxia]

The 2024 International Congress for Ataxia Research (#ICAR2024) kicks off today in London, bringing together 600+ researchers and professionals from 32 countries to advance #ataxia research and treatments.

https://t.co/CaGN8We2m1

[Francesca Maltecca @FrancescaMalt12]

Beautiful dinner with colleagues and friends at #icar_ataxia in London

[Mitocon @MitoconOdv]

🌟📣 Save the date!

📆 🧬 Dal 25 al 27 ottobre 2024, torna a Padova la XIV edizione del 𝐂𝐨𝐧𝐯𝐞𝐠𝐧𝐨 𝐍𝐚𝐳𝐢𝐨𝐧𝐚𝐥𝐞 𝐬𝐮𝐥𝐥𝐞 𝐌𝐚𝐥𝐚𝐭𝐭𝐢𝐞 𝐌𝐢𝐭𝐨𝐜𝐨𝐧𝐝𝐫𝐢𝐚𝐥𝐢.

🔗 Prenota il tuo posto al link:
https://t.co/gCLg7C9OEM

[Francesca Maltecca @FrancescaMalt12]

Happy to share our latest article on #ARSACS, with important implications for molecular diagnosis! Congrats to @DanieleRitis
https://t.co/shHnNILGyY

[Università Vita-Salute San Raffaele @MyUniSR]

Nuove prospettive nella ricerca sulla SPAX5: Sephin-1 come possibile terapia. Leggi l'articolo per saperne di più sul nuovo studio dei ricercatori di @SanRaffaeleMI e UniSR 👉https://t.co/RVqyBq5lwx

[Francesca Maltecca @FrancescaMalt12]

Happy to share our latest Brain paper on mitochondria-mediated stress response in Spastic ataxia type 5 https://t.co/Ja4r9jLpBq

[National Ataxia Foundation @NAF_Ataxia]

Congratulations to @FrancescaMalt12 & her team for their recently published paper in Brain! In this NAF-funded project, they examined how activation of the integrated stress response improves mitochondrial health in Spastic Ataxia type 5 (SPAX5) cells. (1/3)

[Francesca Maltecca @FrancescaMalt12]

Wonderful ARSACS symposium in Montreal organized by @Soniagobe bringing together basic researchers, clinicians and patients.